Therein lies the dilemma.
China is the biggest industrial market where FLC is making in roads, yet the market is worried that FLC is not getting enough diversification, too concentrated in China, not comfortable with China risk etc. In the meantime, the USA is too UN-uniform in the approval process and slow in its take-up.
I have to admit. DEM is a lot more amiable to a western based audience because the customers are brands we can identify with, Coke et al.
Maybe FLC should list in HK, closer to an audience amicable to exposure to China markets.
- Forums
- ASX - By Stock
- FLC
- Ann: Fluence Announces Key Orders In China and SE Asia
Ann: Fluence Announces Key Orders In China and SE Asia, page-44
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FLC (ASX) to my watchlist
|
|||||
Last
13.0¢ |
Change
0.010(8.33%) |
Mkt cap ! $140.5M |
Open | High | Low | Value | Volume |
12.5¢ | 13.0¢ | 12.0¢ | $7.328K | 60.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 145000 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 126036 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 145000 | 0.120 |
2 | 150663 | 0.115 |
5 | 216167 | 0.110 |
1 | 50000 | 0.105 |
1 | 200000 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 126036 | 4 |
0.135 | 50000 | 1 |
0.140 | 56092 | 3 |
0.145 | 120000 | 3 |
0.150 | 146000 | 4 |
Last trade - 13.21pm 15/07/2024 (20 minute delay) ? |
Featured News
FLC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online